XBiotech (XBIT) Statistics

XBiotech Inc (XBIT) is a biopharmaceutical company that is focused on developing and commercializing next-generation antibody therapies for the treatment of various diseases. The company's stock statistics provide valuable insights into its performance in the market. By analyzing these statistics, investors can evaluate the company's financial health and make informed investment decisions. XBiotech Inc's valuation metrics, such as price-to-earnings ratio and market capitalization, help determine the fair value of its stock. Fundamental analysis of XBiotech Inc includes examining its financial statements and key ratios, such as earnings per share and return on equity, to assess its overall profitability and efficiency.

When comparing XBiotech Inc's stock performance against its sector, investors can gauge whether the company is outperforming or underperforming its industry peers. This analysis can provide valuable insights into the company's competitive position and growth potential. XBiotech Inc's revenue per share is a key measure of its financial performance. It indicates how much revenue the company generates for each outstanding share of its stock. This metric helps investors assess the company's revenue-generating capability and growth prospects. XBiotech Inc's Enterprise to EBITDA ratio is a measure of its debt and earning power. It shows how many times the company's Enterprise Value exceeds its Earnings Before Interest, Taxes, Depreciation, and Amortization. A lower ratio indicates better financial health and profitability.